CVC Capital Partners has appointed Fazle Husain as a partner and head of US healthcare.
Husain will be based in CVC’s New York office and will join the firm in January.
Husain joins CVC from the private equity firm Metalmark Capital where he was head of healthcare investing, having joined in 2007.
Prior to joining Metalmark, Fazle was a managing director at Morgan Stanley in the private equity business, where he spent 18 years. He has a track record of investing in healthcare companies for over 25 years, including investments in the healthcare service, medical device, specialty pharmaceuticals and healthcare information technology sectors. He has invested in, and/or served on the boards of several private and public companies, including Allscripts, Cross Country Healthcare, Healogics, Vanguard Healthcare Systems, Aegis Sciences, SouthernCare, Collagen Matrix, The Medicines Company, Cardiac Pathways, Suros Surgical, Healthstream, Quintiles Transnational, Cytyc Corp and IntegraMed America.
Husain’s appointment follows the hiring of Cathrin Petty as head of European healthcare. It is also the third senior hire for CVC’s US team this year, following the appointments of Tom Kichler as US head of industrials and energy, and Chris Colpitts as US head of TMT.
Chris Stadler, managing partner at CVC Capital Partners, says: “Fazle brings a wealth of knowledge about the US healthcare market, which will allow us to create a truly global healthcare team. With him on board, we will also have five sector teams working across our New York and San Francisco offices, covering consumer/retail, financial and business services, TMT, industrials and now healthcare, greatly increasing the scope of our activity across the continent. I look forward to working with Fazle as we continue to identify investment opportunities across the healthcare space.”
Husain adds: “I am very excited to be joining a firm with such a strong global network and excellent track record. The US healthcare market is rapidly transforming, impacted by both regulatory and technology changes, creating attractive investment opportunities. I look forward to working with Cathrin, Chris and the broader CVC team.”